Literature DB >> 16872234

Do older adults using NSAIDs have a reduced risk of colorectal cancer?

Michael Hoffmeister1, Jenny Chang-Claude, Hermann Brenner.   

Abstract

BACKGROUND AND OBJECTIVES: Colorectal cancer (CRC) is primarily a disease of older adults. Although NSAIDs are thought to protect from CRC, and long-term use of NSAIDs is common in the elderly, little is known about the impact of NSAID use on CRC risk at advanced age. We specifically reviewed current evidence regarding the effects of NSAIDs on CRC risk in individuals aged > or =65 years, a rapidly growing age group. STUDY
DESIGN: We searched all articles in PubMed published before August 2005. Studies were included if a subgroup analysis of older adults (> or =65 years of age) was performed, or if long-term use of NSAIDs for > or =5 years and CRC risk was investigated. From the selected studies, relevant information, including sample characteristics and association with CRC risk, was extracted and compared.
RESULTS: Altogether 19 studies were identified. Only four studies specifically considered NSAID use in people > or =65 years of age; of these, two showed risk reduction for CRC comparable to that seen in younger age groups or in all age groups. The most informative observational studies found decreasing relative risk of CRC with increasing duration of NSAID use, suggesting substantial risk reduction after 10-20 years of regular use.
CONCLUSIONS: The available data on long-term effects of NSAID use in elderly people are sparse but predominantly indicate risk reduction for CRC comparable to that seen in younger age groups or all ages. Whether and to what degree initiating NSAID use in old age prevents CRC is essentially unknown. In light of the potential adverse effects of NSAIDs, including recent data on adverse cardiovascular outcomes, more information is needed on the minimum effective dose of NSAIDs and the duration of use required in order to evaluate individual risks and benefits in older adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872234     DOI: 10.2165/00002512-200623060-00006

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  52 in total

1.  Increase of maximum life-span in Sweden, 1861-1999.

Authors:  J R Wilmoth; L J Deegan; H Lundström; S Horiuchi
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

2.  Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Authors:  Jeffrey S Berger; Maria C Roncaglioni; Fausto Avanzini; Ierta Pangrazzi; Gianni Tognoni; David L Brown
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

3.  Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.

Authors:  L Rosenberg; C Louik; S Shapiro
Journal:  Cancer       Date:  1998-06-15       Impact factor: 6.860

Review 4.  Nonsteroidal anti-inflammatory drugs and cancer prevention.

Authors:  J A Baron; R S Sandler
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

5.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

Review 6.  Epidemiology of colorectal cancer.

Authors:  Peter Boyle; Maria Elena Leon
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

Review 7.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

Authors:  P H Gann; J E Manson; R J Glynn; J E Buring; C H Hennekens
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

10.  Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer.

Authors:  M Juarranz; M-E Calle-Purón; A González-Navarro; E Regidor-Poyatos; T Soriano; D Martínez-Hernandez; V-D Rojas; V F Guinee
Journal:  Eur J Cancer Prev       Date:  2002-10       Impact factor: 2.497

View more
  3 in total

1.  Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia.

Authors:  Heike Ursula Krämer; Heiko Müller; Christa Stegmaier; Dietrich Rothenbacher; Elke Raum; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2012-04-22       Impact factor: 8.082

2.  Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.

Authors:  Christine Cole Johnson; Richard B Hayes; Robert E Schoen; Marc J Gunter; Wen-Yi Huang
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

Review 3.  The role of hypoxia in inflammatory disease (review).

Authors:  John Biddlestone; Daniel Bandarra; Sonia Rocha
Journal:  Int J Mol Med       Date:  2015-01-27       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.